LRRC2 | Leucine rich repeat containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PEBP4 | Phosphatidylethanolamine-binding protein 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
RGS20 | Regulator of G-protein signaling 20 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SEMA3D | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D | Predicted intracellular proteins
| | | | | Group enriched |
SLC5A8 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8 | Predicted membrane proteins
| | | | | Tissue enriched |
SLITRK5 | SLIT and NTRK-like family, member 5 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
TCERG1L | Transcription elongation regulator 1-like | Predicted intracellular proteins
| | | | | Tissue enriched |
TMEM215 | Transmembrane protein 215 | Predicted membrane proteins
| | | | | Group enriched |
ANKRD18A | Ankyrin repeat domain 18A | Predicted intracellular proteins
| | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted secreted proteins
| | | | | Group enriched |
CYP27B1 | Cytochrome P450, family 27, subfamily B, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
DIO2 | Deiodinase, iodothyronine, type II | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FKSG66 | | Predicted intracellular proteins
| | | | | Tissue enriched |
HHIPL2 | HHIP-like 2 | Predicted secreted proteins
| | | | | Group enriched |
IGFBPL1 | Insulin-like growth factor binding protein-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
KIAA1456 | KIAA1456 | Predicted intracellular proteins
| | | | | Tissue enriched |
LRP8 | Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PAX8 | Paired box 8 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PCDHGC4 | Protocadherin gamma subfamily C, 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PKHD1L1 | Polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 | Predicted membrane proteins
| | | | | Group enriched |
RTN4RL2 | Reticulon 4 receptor-like 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM232 | Transmembrane protein 232 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
TNFRSF11B | Tumor necrosis factor receptor superfamily, member 11b | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
FKSG66 | | Predicted intracellular proteins
| | | | | Tissue enriched |
GPR110 | G protein-coupled receptor 110 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GRK1 | G protein-coupled receptor kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
KCNA2 | Potassium voltage-gated channel, shaker-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LGI3 | Leucine-rich repeat LGI family, member 3 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LRP1B | Low density lipoprotein receptor-related protein 1B | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MT1F | Metallothionein 1F | Predicted intracellular proteins
| | | | | Group enriched |
MT1H | Metallothionein 1H | Predicted intracellular proteins
| | | | | Group enriched |
RGS16 | Regulator of G-protein signaling 16 | Predicted intracellular proteins
| | | | | Tissue enriched |
SAMD15 | Sterile alpha motif domain containing 15 | Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
TCFL5 | Transcription factor-like 5 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
AC090154.1 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
BMP7 | Bone morphogenetic protein 7 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BMP8B | Bone morphogenetic protein 8b | Predicted secreted proteins
| | | | | Tissue enhanced |
BTBD11 | BTB (POZ) domain containing 11 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf56 | Chromosome 15 open reading frame 56 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1QL4 | Complement component 1, q subcomponent-like 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
CD24 | CD24 molecule | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |